Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)A Study to Evaluate Safety, Tolerability and pK of Semaglutide ER Injectable Suspension in Healthy, Adult Human Subjects
Phase 1
Not yet recruiting
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2024-05-21
- Last Posted Date
- 2024-05-22
- Lead Sponsor
- Bostal Drug Delivery Co., Ltd
- Target Recruit Count
- 14
- Registration Number
- NCT06422624
News
No news found